Maggie Lam
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 32 | 2026 | 1195 | 5.000 |
Why?
| | Proteome | 20 | 2025 | 518 | 3.540 |
Why?
| | Myocardium | 15 | 2026 | 939 | 3.220 |
Why?
| | Alternative Splicing | 5 | 2025 | 247 | 2.130 |
Why?
| | Protein Isoforms | 4 | 2025 | 402 | 1.670 |
Why?
| | Proteins | 9 | 2026 | 1021 | 1.580 |
Why?
| | Mitochondria, Heart | 7 | 2016 | 102 | 1.380 |
Why?
| | Bibliometrics | 3 | 2019 | 63 | 1.250 |
Why?
| | Muscle Proteins | 6 | 2025 | 244 | 1.130 |
Why?
| | Heart | 2 | 2025 | 636 | 1.000 |
Why?
| | Computational Biology | 3 | 2025 | 680 | 0.980 |
Why?
| | Mitochondrial Proteins | 5 | 2015 | 262 | 0.870 |
Why?
| | Mass Spectrometry | 11 | 2026 | 750 | 0.850 |
Why?
| | Chromatography, Reverse-Phase | 4 | 2012 | 27 | 0.850 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2024 | 43 | 0.800 |
Why?
| | Heart Diseases | 2 | 2026 | 349 | 0.790 |
Why?
| | Proteogenomics | 1 | 2022 | 12 | 0.740 |
Why?
| | Data Mining | 3 | 2019 | 117 | 0.740 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2168 | 0.690 |
Why?
| | Deuterium Oxide | 5 | 2026 | 20 | 0.690 |
Why?
| | Disease | 2 | 2020 | 98 | 0.690 |
Why?
| | Paraquat | 1 | 2020 | 13 | 0.660 |
Why?
| | Robotics | 1 | 2021 | 87 | 0.640 |
Why?
| | Semantics | 1 | 2018 | 100 | 0.540 |
Why?
| | Quinolines | 1 | 2018 | 193 | 0.490 |
Why?
| | Down Syndrome | 1 | 2023 | 534 | 0.470 |
Why?
| | Myocytes, Cardiac | 5 | 2025 | 556 | 0.470 |
Why?
| | Mice | 23 | 2025 | 18339 | 0.460 |
Why?
| | Oxidative Stress | 2 | 2020 | 1339 | 0.460 |
Why?
| | Research | 2 | 2015 | 431 | 0.450 |
Why?
| | Animals | 35 | 2026 | 38058 | 0.440 |
Why?
| | Cardiovascular System | 2 | 2016 | 137 | 0.430 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2014 | 159 | 0.410 |
Why?
| | Ubiquitination | 1 | 2014 | 118 | 0.410 |
Why?
| | Isoproterenol | 1 | 2014 | 97 | 0.400 |
Why?
| | Biomedical Research | 2 | 2018 | 710 | 0.400 |
Why?
| | Cyclophilins | 1 | 2013 | 40 | 0.400 |
Why?
| | Biomarkers | 5 | 2026 | 4271 | 0.400 |
Why?
| | Cardiology | 1 | 2016 | 353 | 0.400 |
Why?
| | Cell Culture Techniques | 2 | 2026 | 375 | 0.380 |
Why?
| | Glycopeptides | 2 | 2011 | 44 | 0.360 |
Why?
| | Lysine | 1 | 2014 | 302 | 0.360 |
Why?
| | Glycomics | 1 | 2011 | 7 | 0.360 |
Why?
| | Graphite | 1 | 2011 | 14 | 0.350 |
Why?
| | Glycoproteins | 2 | 2010 | 355 | 0.340 |
Why?
| | Transcriptome | 5 | 2025 | 1045 | 0.330 |
Why?
| | Tandem Mass Spectrometry | 4 | 2021 | 576 | 0.290 |
Why?
| | Humans | 33 | 2026 | 144759 | 0.270 |
Why?
| | Deuterium | 2 | 2025 | 100 | 0.270 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2155 | 0.250 |
Why?
| | Chromatography, Liquid | 4 | 2012 | 454 | 0.240 |
Why?
| | Isotope Labeling | 2 | 2025 | 82 | 0.240 |
Why?
| | Sarcomeres | 2 | 2025 | 98 | 0.230 |
Why?
| | Cell Compartmentation | 1 | 2025 | 54 | 0.230 |
Why?
| | Peptides | 5 | 2025 | 995 | 0.230 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2930 | 0.230 |
Why?
| | Blood Proteins | 3 | 2025 | 249 | 0.220 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2025 | 276 | 0.210 |
Why?
| | Tensins | 1 | 2024 | 5 | 0.210 |
Why?
| | LIM Domain Proteins | 1 | 2024 | 21 | 0.210 |
Why?
| | Proteostasis | 1 | 2024 | 27 | 0.200 |
Why?
| | Heart Ventricles | 3 | 2024 | 760 | 0.200 |
Why?
| | Aging | 3 | 2023 | 1966 | 0.200 |
Why?
| | Organ Specificity | 1 | 2024 | 312 | 0.200 |
Why?
| | Heart Atria | 1 | 2024 | 144 | 0.190 |
Why?
| | Databases, Protein | 2 | 2013 | 90 | 0.190 |
Why?
| | Cell Line | 4 | 2019 | 2882 | 0.190 |
Why?
| | Polysaccharides | 3 | 2011 | 87 | 0.180 |
Why?
| | Myofibrils | 1 | 2022 | 49 | 0.180 |
Why?
| | Muscle, Striated | 1 | 2021 | 12 | 0.170 |
Why?
| | Automation | 1 | 2021 | 102 | 0.170 |
Why?
| | Ventricular Remodeling | 2 | 2021 | 276 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.170 |
Why?
| | Heart Failure | 3 | 2022 | 2323 | 0.170 |
Why?
| | Male | 12 | 2025 | 72315 | 0.170 |
Why?
| | Signal Transduction | 2 | 2025 | 5226 | 0.170 |
Why?
| | Cyclic N-Oxides | 1 | 2020 | 33 | 0.170 |
Why?
| | Equipment Design | 3 | 2011 | 530 | 0.170 |
Why?
| | Laboratories | 1 | 2021 | 109 | 0.160 |
Why?
| | RNA Splicing | 1 | 2022 | 284 | 0.160 |
Why?
| | Spin Labels | 1 | 2020 | 59 | 0.160 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 80 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1782 | 0.160 |
Why?
| | RNA-Binding Proteins | 2 | 2022 | 462 | 0.160 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 65 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2025 | 905 | 0.160 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 84 | 0.160 |
Why?
| | Embryonic Stem Cells | 1 | 2021 | 130 | 0.160 |
Why?
| | Protein Binding | 2 | 2024 | 2273 | 0.160 |
Why?
| | Specimen Handling | 1 | 2021 | 186 | 0.150 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 85 | 0.150 |
Why?
| | Extracellular Matrix | 2 | 2021 | 553 | 0.150 |
Why?
| | Cardiomegaly | 2 | 2018 | 174 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 220 | 0.150 |
Why?
| | Piperidines | 1 | 2020 | 217 | 0.140 |
Why?
| | Cell Differentiation | 3 | 2025 | 2050 | 0.140 |
Why?
| | Doxorubicin | 1 | 2021 | 397 | 0.140 |
Why?
| | Proteolysis | 2 | 2025 | 173 | 0.140 |
Why?
| | Rheumatic Diseases | 1 | 2019 | 97 | 0.140 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 105 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2019 | 143 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1795 | 0.130 |
Why?
| | Phosphorylation | 2 | 2012 | 1732 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2023 | 790 | 0.130 |
Why?
| | Female | 8 | 2025 | 78271 | 0.130 |
Why?
| | Mitochondria | 2 | 2015 | 984 | 0.130 |
Why?
| | Early Diagnosis | 1 | 2018 | 249 | 0.120 |
Why?
| | Kinetics | 2 | 2025 | 1627 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 459 | 0.120 |
Why?
| | Brain Chemistry | 1 | 2016 | 116 | 0.120 |
Why?
| | Alu Elements | 1 | 2016 | 29 | 0.120 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 463 | 0.110 |
Why?
| | Chromatin | 1 | 2019 | 561 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3409 | 0.110 |
Why?
| | Primates | 1 | 2016 | 132 | 0.110 |
Why?
| | Machine Learning | 1 | 2021 | 585 | 0.110 |
Why?
| | Eye | 1 | 2015 | 109 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2019 | 748 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 192 | 0.100 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 113 | 0.100 |
Why?
| | Cattle | 3 | 2012 | 1000 | 0.100 |
Why?
| | Chloroplasts | 2 | 2011 | 17 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2014 | 92 | 0.100 |
Why?
| | Acetylation | 1 | 2014 | 252 | 0.100 |
Why?
| | Systems Integration | 1 | 2013 | 36 | 0.100 |
Why?
| | Knowledge Bases | 1 | 2013 | 28 | 0.100 |
Why?
| | Genome, Human | 1 | 2016 | 422 | 0.100 |
Why?
| | Liver | 2 | 2025 | 1887 | 0.100 |
Why?
| | Intestines | 1 | 2016 | 358 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 920 | 0.100 |
Why?
| | Systems Biology | 1 | 2013 | 72 | 0.090 |
Why?
| | Arabidopsis Proteins | 2 | 2011 | 76 | 0.090 |
Why?
| | Peptide Library | 1 | 2013 | 95 | 0.090 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 70 | 0.090 |
Why?
| | Switzerland | 1 | 2012 | 46 | 0.090 |
Why?
| | Calcium Signaling | 1 | 2014 | 251 | 0.090 |
Why?
| | Carbohydrate Conformation | 1 | 2011 | 15 | 0.090 |
Why?
| | Concanavalin A | 1 | 2011 | 71 | 0.090 |
Why?
| | International Cooperation | 1 | 2012 | 198 | 0.080 |
Why?
| | Protein Conformation | 1 | 2014 | 946 | 0.080 |
Why?
| | Peptide Hydrolases | 1 | 2012 | 105 | 0.080 |
Why?
| | Peptide Mapping | 1 | 2011 | 63 | 0.080 |
Why?
| | Transcription Factors | 1 | 2019 | 1741 | 0.080 |
Why?
| | Chromatography, Ion Exchange | 1 | 2011 | 57 | 0.080 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 427 | 0.080 |
Why?
| | Half-Life | 2 | 2026 | 151 | 0.080 |
Why?
| | Serum | 1 | 2010 | 58 | 0.080 |
Why?
| | Oryza | 1 | 2010 | 32 | 0.080 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 318 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2010 | 245 | 0.080 |
Why?
| | Plant Proteins | 1 | 2010 | 112 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 396 | 0.070 |
Why?
| | Nitric Oxide Synthase | 1 | 2010 | 235 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 458 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 179 | 0.070 |
Why?
| | Arabidopsis | 1 | 2010 | 95 | 0.070 |
Why?
| | Models, Molecular | 1 | 2014 | 1618 | 0.070 |
Why?
| | Kidney | 1 | 2016 | 1495 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 594 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 699 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5992 | 0.060 |
Why?
| | Galectin 3 | 1 | 2025 | 21 | 0.060 |
Why?
| | Galectins | 1 | 2025 | 27 | 0.060 |
Why?
| | Rats | 3 | 2022 | 5597 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2025 | 4154 | 0.050 |
Why?
| | Algorithms | 1 | 2013 | 1837 | 0.050 |
Why?
| | Fibroblasts | 2 | 2025 | 1034 | 0.050 |
Why?
| | Consensus | 1 | 2026 | 488 | 0.050 |
Why?
| | Unfolded Protein Response | 1 | 2024 | 60 | 0.050 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3540 | 0.050 |
Why?
| | Lung | 1 | 2016 | 4109 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2021 | 2027 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 2608 | 0.050 |
Why?
| | Histone Deacetylase 6 | 1 | 2022 | 17 | 0.050 |
Why?
| | Connectin | 1 | 2022 | 42 | 0.050 |
Why?
| | Cats | 1 | 2022 | 228 | 0.050 |
Why?
| | Amino Acids | 1 | 2026 | 521 | 0.040 |
Why?
| | Water | 1 | 2025 | 469 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 26 | 0.040 |
Why?
| | Cardiotoxicity | 1 | 2021 | 33 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4557 | 0.040 |
Why?
| | Human Genome Project | 1 | 2020 | 15 | 0.040 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2020 | 31 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 369 | 0.040 |
Why?
| | Teratoma | 1 | 2021 | 120 | 0.040 |
Why?
| | Software | 1 | 2025 | 690 | 0.040 |
Why?
| | Cell Death | 1 | 2021 | 383 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2020 | 292 | 0.040 |
Why?
| | Stroke Volume | 1 | 2022 | 651 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 541 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2020 | 271 | 0.040 |
Why?
| | Azepines | 1 | 2019 | 107 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2020 | 276 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 266 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 178 | 0.030 |
Why?
| | Atrial Remodeling | 1 | 2018 | 10 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2026 | 1560 | 0.030 |
Why?
| | Homeostasis | 2 | 2012 | 640 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 621 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 192 | 0.030 |
Why?
| | Triazoles | 1 | 2019 | 184 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2018 | 187 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 397 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2019 | 196 | 0.030 |
Why?
| | Fibrosis | 1 | 2019 | 548 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 479 | 0.030 |
Why?
| | RNA Editing | 1 | 2016 | 26 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2019 | 351 | 0.030 |
Why?
| | Adenosine Deaminase | 1 | 2016 | 43 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1253 | 0.030 |
Why?
| | RNA Stability | 1 | 2016 | 119 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 574 | 0.030 |
Why?
| | Exons | 1 | 2016 | 358 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2832 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 684 | 0.030 |
Why?
| | Mammals | 1 | 2016 | 293 | 0.030 |
Why?
| | Adult | 2 | 2014 | 40449 | 0.030 |
Why?
| | Software Design | 1 | 2013 | 25 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2527 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2496 | 0.020 |
Why?
| | Smoking | 1 | 2020 | 1472 | 0.020 |
Why?
| | Access to Information | 1 | 2013 | 48 | 0.020 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 98 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2430 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 549 | 0.020 |
Why?
| | Cytoprotection | 1 | 2012 | 55 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2012 | 73 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 110 | 0.020 |
Why?
| | Drosophila | 1 | 2013 | 166 | 0.020 |
Why?
| | Workflow | 1 | 2013 | 184 | 0.020 |
Why?
| | Oxidants | 1 | 2012 | 103 | 0.020 |
Why?
| | Automation, Laboratory | 1 | 2011 | 7 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 299 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 388 | 0.020 |
Why?
| | Cations | 1 | 2011 | 82 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2011 | 173 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1169 | 0.020 |
Why?
| | Suppression, Genetic | 1 | 2010 | 26 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2010 | 66 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 336 | 0.020 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 26 | 0.020 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2010 | 57 | 0.020 |
Why?
| | Ribonucleases | 1 | 2010 | 49 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2016 | 935 | 0.020 |
Why?
| | Trypsin | 1 | 2010 | 76 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2010 | 93 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2013 | 337 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2011 | 561 | 0.020 |
Why?
| | Solvents | 1 | 2010 | 113 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 366 | 0.020 |
Why?
| | Serum Albumin | 1 | 2010 | 147 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 441 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2012 | 419 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 476 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 311 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 579 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 675 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1833 | 0.010 |
Why?
| | Mutation | 1 | 2010 | 4089 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14105 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 35875 | 0.010 |
Why?
|
|
Lam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|